Grade: Pharmaceutical Grade

Factory Location: Xiamen, Fujian

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East

Monthly Production Capacity: 1000kg

Packaging Information: 25kg/drum 1kg/bottle

Delivery Lead Time: 7 days after payment

Sample Provided: yes

Payment Terms: L/L

 

Product Information

 

Product name	Nifuratel
CAS No.	4936-47-4
Molecular Formula	C10H11N3O5S
Molecular Weight	285.276
Quality Standard	98.5% up
Appearance	Yellow crystalline powder

 

COA of Nifuratel

 

ITEMS	SPECIFICATIONS	RESULTS
Appearance	Yellow crystalline powder	Confirms
Melting Point	186.0 。C - 189.0。C	186.3。C-186.7。C
PH	5.8- 7.4	7.14
Color of solution	Not deeper than No.5	Confirms
Single impurity	≤ 0.1%	0.09%%
Total impurity	≤ 1.0%	0.25%
Loss on drying	≤ 0.5%	0.13%
Residual on ignition	≤ 0.1%	0.03%
Assay	98.5%-101.5%	99.9%
Conclusion	Complies with the enterprise standard

 

Usage

 

Function of Nifuratel

Nifuratel is a gynecological antibacterial drug, mainly used for the treatment of bacterial vaginitis, trichomonal vaginitis, candidal vaginitis and vulvitis, in addition to urinary system infections and digestive amebiasis and Giardiasis and so on.

Nifuratel can be quickly absorbed after oral administration. The peak blood concentration can be reached within 2 hours, and there are reports of high concentration in saliva and vaginal secretions. The half-life is 2.75 hours. Nifuratel is also rapidly metabolized, and most of the oral nifuratel is excreted through the kidneys. Together with the two active metabolites, it is excreted in the urine, and the original drug and metabolites can also be excreted in milk. Nifuratel is effective against bacteria, trichomoniasis and candida that cause infections in women's reproductive system. This product mainly inhibits the growth of bacteria by interfering with its enzyme system. It is difficult to penetrate the placenta and has no teratogenic effect.